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Introduction
Until 1999, men with non-obstructive azoospermia (NOA) did
not have an option to conceive using their sperm [1]. Since the
advent of microdissection testicular sperm extraction
(MicroTESE), men with NOA have a chance to conceive by
using their sperm for in vitro fertilization/intracytoplasmic sperm
injection (IVF/ICSI). With more widespread use of serum
antimüllerian hormone (AMH) testing to assist in the evaluation
of diminished ovarian reserve (DOR), the controversy of appro-
priate options for couples with both of these obstacles has arisen.
Materials and methods
This case is reported after chart review of a successful
outcome.
Results
A 47 year old man with NOA and his 42 year old wife with
DOR were evaluated for subfertility in a couples fertility center
by a Reproductive Endocrinologist (SKK) and a Reproductive
Urologist (PKK). The male partner was found to have 9 cc
volume testes on physical examination and did not have a pal-
pable varicocele. Hewas found to be azoospermic on two semen
analyses with normal semen volumes on both. His gonadotro-
pins were normal with an FSH level of 4.1 mIU/ml and an LH
level of 3.2 mIU/ml; his prolactin level was 9.8 ng/ml. He was
eugonadal with a testosterone of 498 ng/dl and an estradiol of
27 pg/ml; therefore, medical treatment was not indicated prior to
MicroTESE. His karyotype revealed a normal 46XY result and
Y chromosome microdeletion assay revealed no microdeletions
in the AZFa, AZFb, or AZFc regions.
They were counseled extensively regarding advanced ma-
ternal age, and elected to proceed with fresh MicroTESE and
IVF/ICSI with the female partner’s own oocytes. The female
partner underwent 12 days of controlled ovarian stimulation
(COS) with 225 IU of recombinant FSH and 75 IU of human
menopausal gonadotropins per day, with an estradiol level of
1143 pg/ml, progesterone level of 0.5 ng/ml, and a trilaminar
appearing endometrium with a thickness of 11.0 mm on the
day of hCG trigger. Sperm were retrieved with unilateral
MicroTESE, sufficient in quantity for the fresh IVF/ICSI case
as well as for surplus sperm cryopreservation into one vial.
Fresh MicroTESE sperm was used for ICSI with five meta-
phase II oocytes (one out of 6 oocytes retrieved was a germi-
nal vesicle). Two of the mature oocytes fertilized normally
into 2PN zygotes, two others had supernumerary nuclei, and
one did not fertilize. The two pronuclear zygotes underwent
cleavage and, in accordance with the Society for Assisted
Reproductive Technology (SART) embryo grading system,
[2] were graded as 5A and 6B on day 3 when embryo transfer
was performed. The patient unfortunately had a negative preg-
nancy test. A small portion of testicular tissue was obtained at
the time of MicroTESE in order to minimize tissue damage
and preserve hormonal testicular function. Histopathology re-
vealed a hypospermatogenesis architectural pattern only.
For their next attempt, when the wife was 43 years of age
with an AMH level of <0.16 ng/ml, they elected to use his
surplus cryopreserved sperm with donor oocyte IVF/ICSI.
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The wife’s endometrial preparation with an estradiol and pro-
gesterone protocol resulted in a trilaminar endometriumwith a
thickness of 15.5 mm. The couple’s oocyte donor underwent
8 days of COS with 225 IU of recombinant FSH and 75 IU of
human menopausal gonadotropins per day, with an estradiol
level of 2266 pg/ml and progesterone level of 0.8 ng/ml on the
day of hCG trigger. Twenty-seven oocytes were retrieved, of
which 17 were metaphase II oocytes. One vial of MicroTESE
sperm was thawed, which yielded a pre-wash, post-thaw
sperm concentration of 1.8 million/ml with 0% motility in a
volume of 1.0 ml. Sperm preparation and pentoxifylline treat-
ment yielded a post-wash sperm concentration of 1.0 million/
ml and 30%motility, 10% progressive motility, in a volume of
0.5 ml. ICSI was performed for the 17 mature oocytes, of
which 11 fertilized and yielded 2PN zygotes and 2 yielded a
1PN embryo; four mature oocytes did not fertilize. Two day 3
embryos, graded 8A and 8B, in accordance with the SART
embryo grading system [2], were used for embryo transfer and
resulted in pregnancy and live birth of healthy dizyogotic
twins. In addition, two surplus blastocysts, each graded as
3BB in accordance with the Gardner embryo grading system,
were cryopreserved [3, 4].
Discussion
One percent of men in the general population are azoospermic,
and 15% of men presenting for a subfertility evaluation will be
found to be azoospermic [5]. In men with NOA, MicroTESE
should be offered by Reproductive Urologists with an expertise
in this operation to provide the highest success rates at retrieval.
As testing for DOR advances, couples may be counseled more
appropriately. There is no more challenging of a scenario in
couples fertility care, than when the male partner has NOA
and the female partner has significant DOR. This case demon-
strates that couples in this situation should be offered
MicroTESE after an appropriate evaluation in efforts to use
the male partner’s sperm. Published successful sperm retrieval
rates with MicroTESE range up to 70% depending on the pa-
thology, and rates are highly surgeon dependent [6–11]. This
case proves that surplus MicroTESE retrieved sperm can be
cryopreserved and used in conjunction with IVF/ICSI with do-
nor oocytes for female partners with DOR to successfully allow
the couple to conceive. The advantages of cryopreserving sur-
plus MicroTESE retrieved sperm obtained prior to COS for
IVF/ICSI has been evaluated [12] and applies to donor oocyte
IVF/ICSI as well. As our understanding of couples fertility
continues to advance, we should continue to offer couples all
of their options, even in highly challenging circumstances.
Conclusions
To our knowledge, this is the first case reported of live birth with
the use of surplus cryopreserved sperm retrieved from a
MicroTESE with donor oocyte IVF/ICSI. In couples with non-
obstructive azoospermia and diminished ovarian reserve,
MicroTESE should be offered and surplus retrieved sperm may
be cryopreserved to be used for ICSI with donor oocytes with a
cycle subsequent to sperm retrieval. DOR should not be a deter-
rent to offering microTESE to these men with NOA. The couple
can be successful with IVF/ICSI with surplus cryopreserved
sperm retrieved at microTESE and donor oocytes.
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